Icon

TREXIMET (nda021926)- (60MG;EQ 10MG BASE,500MG;EQ 85MG BASE)

NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE CURRAX
60MG;EQ 10MG BASE,500MG;EQ 85MG BASE
Yes Yes
2026-Apr-02 Expired
None None
None No
TREXIMET is a combination of sumatriptan, a serotonin (5-HT) 1b/1d receptor agonist (triptan), and naproxen sodium, a non-steroidal anti-inflammatory drug, indicated for the acute treatment of migraine with or without aura in adults and pediatric patients 12 years of age and older.
3 2 2
Total Other Developers 2
Drugs with Suitability No
60MG;EQ 10MG BASE ** ** - - -
500MG;EQ 85MG BASE ** ** - - 2
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** ***** *** ************** ********** ******* *********** ****** **. ****, *****, ***** ********* ** ***** *** ***** ****** *** ***** *** *** ******, ***** (***) ***
****** ********* ****** *** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.